Epigenetic inactivation of RUNX3 is tightly linked to the early stages of bladder, lung, and gastrointestinal carcinogenesis, suggesting that RUNX3 is a potential tumor-suppressor. This evidence concerns the gene RUNX3 and neoplasm.